CLASS II Drug recall · Reported 16 Apr 2025 · FDA Enforcement Report

Sofosbuvir and Velpatasvir, 400 mg/: blister cards recalled

Asegua Therapeutics is recalling Sofosbuvir and Velpatasvir, 400 mg/: blister cards, distributed nationwide in the US. The recall was initiated on 7 Mar 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot# 24ASV002UA, Exp Date: 6/30/2028
NDC72626-2701
Quantity recalled18,541 cartons.

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0313-2025
FDA event ID
96434
Recalling firm
Asegua Therapeutics, Foster City, CA
Manufacturer
Asegua Therapeutics LLC
Classification
Class II
Status
Terminated
Recall initiated
7 Mar 2025
FDA classified
7 Apr 2025
Reported
16 Apr 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

7 Mar 2025Recall initiated by company
7 Apr 2025Classified by FDA+31 days
16 Apr 2025Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Defective Container: blister packs not properly sealed resulting in tablets being loose in the carton.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Sofosbuvir and Velpatasvir, 400 mg/100 mg tablets, 28 tablets: 2x14 blister cards, Rx Only, Manufactured for: Asegua Therapeutics LLC an affiliate of Gilead Sciences, Inc., Foster City, CA 94404, Made in Ireland, NDC# 72626-2701-1

Where it was distributed

US Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Defective Container: blister packs not properly sealed resulting in tablets being loose in the carton.

Which lots are affected?

Lot# 24ASV002UA, Exp Date: 6/30/2028

Where was it sold?

US Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 9 Oct 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.